CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea

Compound could be a game-changer for dangerous pathogen

A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication.

Read More